The Week

Palantir Tech rose 6.22% this week to close at $177.64, up from a previous close of $167.23. The S&P 500 slipped 0.08% over the same period, meaning Palantir outperformed the benchmark by roughly 6.3 percentage points. On the daily bars, Monday opened at $169.695 and dipped to an intraday low of $166.42 before recovering, Tuesday pushed as high as $176.59, and the following three sessions traded between $172 and $177.88. The stock finished Friday at $177.64, just shy of the weekly high of $177.88, reflecting a mostly firm tone through the week. Weekly amplitude was 6.75% on total volume of 144.45m shares.

Key Events

The week’s news flow split into three broad threads. First, UBS named Palantir its ‘best AI enabler’ and included the stock in its top tech picks, while Jim Cramer reaffirmed a $250 target price on Friday. Second, the company added tangible deployments: its NHS platform expanded into GP patient data sharing, and Chipotle began piloting Palantir’s food safety risk platform after a summer of food safety incidents. Third, the debate over AI valuations heated up, as Michael Burry said he is short AI giants Nvidia and Palantir and warned of a possible 1987-style drawdown, while other commentary argued the short thesis misses part of Palantir’s bull case. Separately, director Alexander D. Moore sold about $2.78m of common shares during the week.

Analyst Ratings

There are 33 institutions covering Palantir: 20 rate it buy, 1 over, 9 hold, 1 under, 1 sell, and 1 has no opinion. That works out to 21 buy or over ratings and 2 under or sell ratings. The consensus recommendation is buy, with a consensus target price of $196.84, roughly 10.81% above the current price of $177.64. The target range is wide, from $80 to $255, showing meaningful dispersion among analysts. Palantir ranks 9th within its industry for analyst ratings, with coverage breadth above the industry average.

The Week Ahead

There are no company-specific earnings for Palantir on the upcoming calendar, so the focus shifts to macro data. Tuesday brings the US Richmond Fed composite index, Wednesday has EIA weekly crude and Cushing crude inventories, and Thursday includes initial jobless claims, the current account balance, new home sales, and EIA natural gas storage changes. Market expectations around the Fed’s next move could still influence valuation sentiment across AI names, so Palantir’s trading pace remains a key watch item as a high-beta AI stock.

In Short

Analyst ratings lean positive, with a buy consensus and a target about 10.81% above spot, while valuation sits elevated at roughly 141.51x P/E and 43.67x P/B. On the latest trading day, large-lot money turned net seller, and a director also trimmed shares, showing that insiders and sell-side views are not fully aligned at current levels. The stock moved higher this week but faces resistance near $178. The next test is whether macro data shifts risk appetite and whether projects like NHS and Chipotle deliver further fundamental follow-through.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.